Nation and world news briefs

AstraZeneca cleared by US regulators to resume vaccine trialAstraZeneca Plc, the U.K. drugmaker developing a coronavirus vaccine with the University of Oxford, has been cleared by U.S. regulators to restart a trial halted in the country for more than a month on concerns about a volunteer who became ill, according to a person familiar with the decision.The person asked not to be identified because the information isn’t public.A decision to allow the study to resume would remove a significant impediment for AstraZeneca and Oxford as they try to get their coronavirus shot across the line. They ar…

Read More

HEDGE accordingly